文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

八十岁以上胸部和肺部癌症患者的治疗:全面老年评估的影响。

Octogenarians treated for thoracic and lung cancers: Impact of comprehensive geriatric assessment.

机构信息

Internal Medicine, Geriatrics and Therapeutic Unit, AP-HM, Marseille, France and Coordination Unit for Geriatric Oncology (UCOG), PACA West, France; Aix-Marseille Univ, CNRS, EFS, ADES, Marseille, France.

Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France; Aix-Marseille Univ, CNRS, INSERM, CRCM, Marseille, France.

出版信息

J Geriatr Oncol. 2021 Apr;12(3):402-409. doi: 10.1016/j.jgo.2020.10.005. Epub 2020 Oct 21.


DOI:10.1016/j.jgo.2020.10.005
PMID:33097456
Abstract

BACKGROUND: Lung cancer affects older and older old adults and is the leading cause of death by cancer. Comprehensive Geriatric Assessment (CGA) is recommended before and during cancer treatment to guide therapy management in this population. METHODS: This study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients 70 years or older referred for a CGA before initiation of lung cancer treatment were enrolled. The objective of this study was to compare lung and thoracic cancer management of octogenarians (≥80 years) and their geriatric profile versus patients aged 70 to 79 years (<80 years). FINDINGS: In our study, 228 patients were recruited. The median age was 78.7 ± 5 years. There were 94 octogenarians (41.2%), 36.2% of them were diagnosed with stage IV neoplasm and the most common treatment was chemotherapy (43.6%). The logistic regression analysis highlights that handgrip strength was the most commonly impaired domain (OR 2.3; 95% CI [1.3-4.3]) in octogenarians and that they are more likely than their younger counterparts to be treated by targeted therapy (OR 9.8; 95% CI [1.0-92.9]). Overall survival (OS) was similar in both age groups (log rank = 0,95). INTERPRETATION: In our study, octogenarians and patients <80 years had equivalent survival, across the different thoracic cancer treatments and tumor stages. Measure of muscle strength in CGA could be very useful in a clinical setting to help improve the management of older old patients treated for lung or thoracic cancer.

摘要

背景:肺癌影响着越来越多的老年人,是癌症死亡的主要原因。在癌症治疗之前和期间,建议进行全面老年评估(CGA),以指导该人群的治疗管理。

方法:这项研究于 2015 年 9 月至 2019 年 1 月在马赛大学医院(AP-HM)进行。在此期间,所有连续接受肺癌治疗前 CGA 评估的 70 岁或以上的门诊患者均被纳入研究。本研究的目的是比较 80 岁及以上的高龄患者(≥80 岁)与 70 至 79 岁患者(<80 岁)的肺癌和胸癌治疗方法及其老年综合评估结果。

发现:在我们的研究中,共纳入 228 例患者。中位年龄为 78.7 ± 5 岁。有 94 例患者(41.2%)为 80 岁以上高龄患者,其中 36.2%的患者被诊断为第四期肿瘤,最常见的治疗方法是化疗(43.6%)。逻辑回归分析显示,握力是高龄患者最常见的受损领域(OR 2.3;95%CI [1.3-4.3]),且他们比年轻患者更有可能接受靶向治疗(OR 9.8;95%CI [1.0-92.9])。两组的总生存期(OS)相似(对数秩检验= 0.95)。

结论:在我们的研究中,高龄患者和 80 岁以下患者在不同的胸部癌症治疗和肿瘤阶段的生存情况相似。CGA 中肌肉力量的测量在临床实践中可能非常有用,可以帮助改善老年患者肺癌或胸癌的治疗管理。

相似文献

[1]
Octogenarians treated for thoracic and lung cancers: Impact of comprehensive geriatric assessment.

J Geriatr Oncol. 2021-4

[2]
Older Patients Treated for Lung and Thoracic Cancers: Unplanned Hospitalizations and Overall Survival.

Clin Lung Cancer. 2021-5

[3]
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study.

Clin Interv Aging. 2020

[4]
Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians.

Ann Thorac Surg. 2008-2

[5]
Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit.

Eur J Cardiothorac Surg. 2010-10-27

[6]
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06).

Lung Cancer. 2018-4-22

[7]
Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer-a follow-up study.

Eur J Cancer. 2019-6-1

[8]
Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?

Lung Cancer. 2021-2

[9]
Use and impact of the G8 score in older patients with thoracic and lung cancers.

Eur Geriatr Med. 2021-10

[10]
Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service.

JCO Oncol Pract. 2023-12

引用本文的文献

[1]
Psoas muscle index as a novel measure of frailty and predictor of post-operative outcome in octogenarians with non-small cell lung cancer.

J Thorac Dis. 2025-2-28

[2]
Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer.

Front Oncol. 2024-7-16

[3]
The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer.

Cancers (Basel). 2023-4-15

[4]
Identifying octogenarians with non-small cell lung cancer who could benefit from surgery: A population-based predictive model.

Front Surg. 2022-7-28

[5]
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care.

Curr Oncol Rep. 2022-11

[6]
A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.

Front Oncol. 2022-3-31

[7]
Measuring Walking Speed Failed to Predict Early Death and Toxicity in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC) Selected for Undergoing First-Line Systemic Treatment: An Observational Exploratory Study.

Cancers (Basel). 2022-3-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索